Pacb Stock Forecast Tipranks

The average price target is $74.91 with a high forecast of $86.00 and a low forecast of $40.00. The stock is rated as a hold by 2 analyst(s), 3 recommend it as a buy and 0 called the pacb stock overweight.

Heres Why You Should Retain Pacbio Pacb Stock For Now Nasdaq

Based on 12 wall street analysts offering 12 month price targets for crispr therapeutics ag in the last 3 months.

Pacb stock forecast tipranks. Pacb | complete pacific biosciences of california inc. Wall street stock market & finance report, prediction for the future: A small number of hedge funds were also right about betting on pacb as the stock returned 14.1% since the end of the fourth quarter (through 4/19) and outperformed the market by an even larger margin.

Pacific biosciences of california, inc. Pacific biosciences of california, inc. You'll find the pacific biosciences of california share forecasts, stock quote and buy / sell signals below.

Pacific biosciences of california has not formally confirmed its next earnings publication date, but the company's estimated earnings date is wednesday, february 9th, 2022 based off prior year's report dates. Pacific biosciences of california inc () stock market info recommendations: In the last three months, pacific biosciences of california inc.

View pacific biosciences of california pacb investment & stock information. Earnings for pacific biosciences of california are expected to decrease in the coming year, from ($0.90) to ($1.07) per share. Based on 3 wall street analysts offering 12 month price targets for zai lab in the last 3 months.

The average price target represents a 28.80% change from the last price of $126.16. Buy or sell pacific biosciences of california stock? Pacific biosciences is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

Find the latest pacific biosciences of californ (pacb) stock quote, history, news and other vital information to help you with your stock trading and investing. The pacific biosciences stock analysis is based on the tipranks smart score which is derived from 8 unique data sets including analyst recommendations, crowd wisdom, hedge fund activity, media sentiment and multiple technical stock factors. Investorsobserver gives pacific biosciences (pacb) an overall rank of 48, which is below average.

According to present data pacific biosciences of california's pacb shares and. Pacb) stock gained 182% and on february 1st it had a closing price of $34.18. Pacific biosciences of california stock forecast by wall street analysts.

In the meantime, 0 analyst(s) believe the stock as underweight and 0 think. Since then, pacb shares have increased by 495.1% and is now trading at $20.47. The report will be for the fiscal quarter.

Pacific biosciences of california, inc. Is expected* to report earnings on 11/02/2021 after market close. Common stock (pacb) nasdaq listed.

The average price target represents a 60.74% change from the last price of $134.17. The highest, average, and lowest price target of all analysts. From $3 dollar per share in march 2020, the company had witnessed its stock price shoot through the roof.

A rank of 48 means that 52% of stocks appear more. Analyst price target on zlab. Pacific biosciences of california, inc.

And the stock is still holding up. The average price target represents a 23.29% change from the last price of $60.76. Based on 13 wall street analysts offering 12 month price targets for uipath in the last 3 months.

Here is what baron discovery fund said. The average price target is $162.50 with a high forecast of $220.00 and a low forecast of $117.00. Pacific biosciences stock rockets ahead of earnings, after softbank makes $900 million investment.

The average price target is $215.67 with a high forecast of $225.00 and a low forecast of $200.00. Softbank to invest $900 million in gene sequencing firm pacific biosciences. Data is currently not available.